Amylyx Pharmaceuticals Inc (AMLX)
1.93
+0.12
(+6.63%)
USD |
NASDAQ |
May 01, 16:00
1.93
0.00 (0.00%)
Pre-Market: 20:00
Amylyx Pharmaceuticals Free Cash Flow: 10.68M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.68M |
| September 30, 2023 | -52.83M |
| June 30, 2023 | -90.84M |
| March 31, 2023 | -146.74M |
| December 31, 2022 | -182.40M |
| Date | Value |
|---|---|
| September 30, 2022 | -160.51M |
| June 30, 2022 | -137.99M |
| March 31, 2022 | -103.47M |
| December 31, 2021 | -75.15M |
Free Cash Flow Range, Past 5 Years
-182.40M
Minimum
Dec 2022
10.68M
Maximum
Dec 2023
-104.36M
Average
-103.47M
Median
Mar 2022
Free Cash Flow Benchmarks
| Cassava Sciences Inc | -82.44M |
| iRhythm Technologies Inc | -90.52M |
| Bristol-Myers Squibb Co | 12.51B |
| Moderna Inc | -3.825B |
| ACADIA Pharmaceuticals Inc | -23.35M |